According to Zhitong Finance App, Fu'an Pharmaceutical (300194.SZ) announced that Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a drug registration certificate for injectable ceftazidime avibatana issued by the State Drug Administration. Injectable ceftazidime avibatana is suitable for treating complex intra-abdominal infections; hospital-acquired pneumonia and ventilator-associated pneumonia; and treatment of infections caused by gram-negative bacteria sensitive to this product in adults and children with limited treatment options.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.